Dr Cedric Edwards, MD | |
590 Highway 6 E, Batesville, MS 38606-3002 | |
(662) 563-8703 | |
Not Available |
Full Name | Dr Cedric Edwards |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 590 Highway 6 E, Batesville, Mississippi |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215224563 | NPI | - | NPPES |
05683563 | Medicaid | MS |
Entity Name | South Sunflower County Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184679292 PECOS PAC ID: 6709771637 Enrollment ID: O20040218000979 |
News Archive
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
The H7N9 avian flu strain that emerged in China earlier this year has subsided for now, but it would be a mistake to be reassured by this apparent lull in infections. The virus has several highly unusual traits that paint a disquieting picture of a pathogen that may yet lead to a pandemic, according to lead scientists from the National Institute of Allergy and Infectious Diseases.
The Universities of Birmingham and Cambridge have launched a new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage.
POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.
As coronavirus spreads across the globe via infected air travelers, authorities are attempting to contain the outbreak and avoid a pandemic.
› Verified 7 days ago
Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
The H7N9 avian flu strain that emerged in China earlier this year has subsided for now, but it would be a mistake to be reassured by this apparent lull in infections. The virus has several highly unusual traits that paint a disquieting picture of a pathogen that may yet lead to a pandemic, according to lead scientists from the National Institute of Allergy and Infectious Diseases.
The Universities of Birmingham and Cambridge have launched a new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage.
POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.
As coronavirus spreads across the globe via infected air travelers, authorities are attempting to contain the outbreak and avoid a pandemic.
› Verified 7 days ago
Entity Name | Magnolia Counseling Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952940454 PECOS PAC ID: 5496176109 Enrollment ID: O20200605000063 |
News Archive
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
The H7N9 avian flu strain that emerged in China earlier this year has subsided for now, but it would be a mistake to be reassured by this apparent lull in infections. The virus has several highly unusual traits that paint a disquieting picture of a pathogen that may yet lead to a pandemic, according to lead scientists from the National Institute of Allergy and Infectious Diseases.
The Universities of Birmingham and Cambridge have launched a new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage.
POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.
As coronavirus spreads across the globe via infected air travelers, authorities are attempting to contain the outbreak and avoid a pandemic.
› Verified 7 days ago
Entity Name | Care Clinic For Drug Addiction & Mental Health In North Mississippi |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659041663 PECOS PAC ID: 4880067875 Enrollment ID: O20230222000004 |
News Archive
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
The H7N9 avian flu strain that emerged in China earlier this year has subsided for now, but it would be a mistake to be reassured by this apparent lull in infections. The virus has several highly unusual traits that paint a disquieting picture of a pathogen that may yet lead to a pandemic, according to lead scientists from the National Institute of Allergy and Infectious Diseases.
The Universities of Birmingham and Cambridge have launched a new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage.
POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.
As coronavirus spreads across the globe via infected air travelers, authorities are attempting to contain the outbreak and avoid a pandemic.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Cedric Edwards, MD 2340 Sunset Dr Ste C, Grenada, MS 38901-2827 Ph: (662) 508-0098 | Dr Cedric Edwards, MD 590 Highway 6 E, Batesville, MS 38606-3002 Ph: (662) 563-8703 |
News Archive
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
The H7N9 avian flu strain that emerged in China earlier this year has subsided for now, but it would be a mistake to be reassured by this apparent lull in infections. The virus has several highly unusual traits that paint a disquieting picture of a pathogen that may yet lead to a pandemic, according to lead scientists from the National Institute of Allergy and Infectious Diseases.
The Universities of Birmingham and Cambridge have launched a new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage.
POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.
As coronavirus spreads across the globe via infected air travelers, authorities are attempting to contain the outbreak and avoid a pandemic.
› Verified 7 days ago
Dr. Johnnie Cummings, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 216 Highway 51 N, Batesville, MS 38606 Phone: 662-563-1858 Fax: 662-563-0617 |